Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma
Pembrolizumab yielded a high rate of durable responses in HIV-associated KS. imAEs were successfully managed with standard guidelines.
Authors
- Angela Shaulov Kask
- Judith C. Kaiser (ORCID: https://orcid.org/0000-0001-7165-7200)
- Michael J. Wagner (ORCID: https://orcid.org/0000-0002-8812-1653)
- Kyle Moore (ORCID: https://orcid.org/0000-0002-1280-241X)
- Kathryn Lurain (ORCID: https://orcid.org/0000-0002-5794-7292)
- Elad Sharon (ORCID: https://orcid.org/0000-0002-0044-9719)
- Steven P. Fling (ORCID: https://orcid.org/0000-0001-6263-0153)
- Philip Friedlander (ORCID: https://orcid.org/0000-0001-6538-1615)
- Anna K. Wright (ORCID: https://orcid.org/0000-0002-1373-712X)
- Thomas Odeny (ORCID: https://orcid.org/0000-0002-1644-2378)
- Elena M. Cornejo Castro
- Chia-Ching Wang
- Nazzarena Labò (ORCID: https://orcid.org/0000-0001-5953-4064)
- Robert Yarchoan (ORCID: https://orcid.org/0000-0002-3057-1395)
- Denise Whitby (ORCID: https://orcid.org/0000-0002-7407-2563)
- Wendell Miley (ORCID: https://orcid.org/0000-0001-8435-9982)
- Thomas S. Uldrick (ORCID: https://orcid.org/0000-0001-6959-0924)
- Vickie Ann Marshall (ORCID: https://orcid.org/0000-0002-4069-185X)
- Nina Bhardwaj (ORCID: https://orcid.org/0000-0003-1865-4187)
- Gaurav Goyal (ORCID: https://orcid.org/0000-0001-6148-5177)
- Vanessa Eulo (ORCID: https://orcid.org/0000-0003-2304-2222)
- Maher Abdul‐Hay (ORCID: https://orcid.org/0000-0003-1041-7689)
- Romin Roshan (ORCID: https://orcid.org/0000-0003-3449-3141)
- Ramya Ramaswami (ORCID: https://orcid.org/0000-0001-5709-4675)
- Irene Ekwede (ORCID: https://orcid.org/0000-0002-6930-7022)
- Manoj Menon (ORCID: https://orcid.org/0000-0002-4981-0376)
- E. S. Han
Institutions
- Leidos (United States) (US)
- National Institutes of Health (US)
- University of California, San Francisco (US)
- University of Washington (US)
- University of Alabama at Birmingham (US)
- NYU Langone Health (US)
- Fred Hutch Cancer Center (US)
- Mount Sinai Hospital (US)
- Dana-Farber Cancer Institute (US)
- Frederick National Laboratory for Cancer Research (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1200/jco.24.00640
- Citations
- 15
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 4.24